4月16日 - ** 制药商Cumberland Pharmaceuticals CPIX.O股价盘前上涨约12.5%至3.60美元
** 该公司称已获得美国食品及药物管理局的批准，可以更广泛地使用Caldolor（一种布洛芬的静脉注射剂）治疗成人和三个月大的儿童手术后的疼痛。
** 批准将 Caldolor 用于治疗轻度至中度疼痛，以及与阿片类药物一起用于治疗严重的术后疼痛
** 该公司补充说，该药可用于退烧，并可减少对成瘾性阿片类止痛药的依赖
** 截至上一交易日收盘，股价年累计下跌约 20%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.